Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 195
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +85 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2 Trial in United States (GLWL-01, Part A, Placebo, Part A, GLWL-01, Part B)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • GLWL-01, Part A
  • +5 more
  • Tempe, Arizona
  • +3 more
Mar 19, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +96 more
Mar 6, 2019

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +2 more
  • Glendale, Arizona
  • +143 more
Jan 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Albuminuria
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +353 more
Nov 19, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in United States (ITCA 650 Osmotic Mini Pump 20/60 mcg/day, ITCA 650 Osmotic Mini Pump 60 mcg/day,

Completed
  • Diabetes Mellitus, Type 2
  • ITCA 650 Osmotic Mini Pump 20/60 mcg/day
  • +3 more
  • Birmingham, Alabama
  • +35 more
Nov 1, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Type 2 Trial in Puerto Rico, United States (Insulin glargine, Inhaled Insulin (Exubera))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine
  • Inhaled Insulin (Exubera)
  • Phoenix, Arizona
  • +72 more
Aug 31, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Type 2 Trial in Worldwide (, linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Sheffield, Alabama
  • +144 more
Jun 1, 2018

Diabetes, Type 2 Trial in United States (Exenatide once weekly suspension, Exenatide twice daily)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Exenatide once weekly suspension
  • Exenatide twice daily
  • Muscle Shoals, Alabama
  • +57 more
Jun 4, 2018

Diabetes, Type 2 Trial in Worldwide (GSK523338)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +84 more
Apr 2, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +60 more
Mar 17, 2018

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +41 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (Placebo, DEN 2.5 mg, DEN 7.5 mg)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Placebo
  • +5 more
  • Long Beach, California
  • +108 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone maleate/metformin HCl)

Completed
  • Diabetes Mellitus, Type 2
  • rosiglitazone maleate/metformin hydrochloride
  • Anniston, Alabama
  • +101 more
Mar 19, 2018